This clinical trial will assess the performance of a liquid biopsy assay to identify cancer in indeterminant pulmonary nodules identified by CT screening of high-risk individuals and evaluate the capability of the liquid biopsy assay to monitor response to surgical resection.
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Indeterminate pulmonary nodule study cohort: Sensitivity and specificity of liquid biopsy test for malignancy
Timeframe: 9 months
Known lung cancer for surgical resection study cohort
Timeframe: 9 months
Healthy volunteers study cohort
Timeframe: 9 months
Benign lung disease cohort
Timeframe: 9 months